<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39337891</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-1729</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>03</Day></PubDate></JournalIssue><Title>Life (Basel, Switzerland)</Title><ISOAbbreviation>Life (Basel)</ISOAbbreviation></Journal><ArticleTitle>Retrospective Analysis of the Effect of Postmenopausal Women Medications on SARS-CoV-2 Infection Progression.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1107</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/life14091107</ELocationID><Abstract><AbstractText>Since the beginning of the COVID-19 pandemic, it has been evident that women and young people were less susceptible to severe infections compared to males. In a previous study, we observed a reduced prevalence of SARS-CoV-2 infections in hormonal-driven breast cancer patients undergoing SERM (selective estrogen receptor modulator) therapy with respect to other treatments inhibiting estrogen synthesis. In addition to being used in anticancer therapy, SERMs are also prescribed for postmenopausal osteoporosis prevention and treatment. Therefore, in this study, a retrospective analysis of the clinical outcomes of SARS-CoV-2 infections in a population of women over 50 years who were treated for the management of menopausal symptoms was performed. SARS-CoV-2 infections, hospitalizations, and death rates were evaluated in women residing in the Italian north-eastern Veneto Region who were undergoing treatment with Estrogen Modulators (EMs); Estrogen or Progestin, and their combination (EPs); Bisphosphonates (BIs); or cholecalciferol (vitamin D3) ± calcium supplementation (CC). The final cohort study included 124,393 women, of whom 6412 were found to be SARS-CoV-2 infected (CoV2+ve). The results indicated that only women treated with vitamin D3 alone or in combination with calcium showed a significant reduction in their SARS-CoV-2 infection risk by 26% (OR 0.74; 95%CI 0.60-0.91). On the other hand, an increased risk of hospitalization (OR 2.69; 95%CI 1.77-4.07) was shown for the same treatments. The results highlighted in this work contribute to shedding some light on the widely debated role of vitamin D in the prevention of SARS-CoV-2 infections and the disease's treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cocetta</LastName><ForeName>Veronica</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-0350-8403</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35122 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zorzi</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6025-5214</Identifier><AffiliationInfo><Affiliation>Veneto Tumour Registry, Azienda Zero, 35131 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bejor</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35122 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cesta</LastName><ForeName>Maria Candida</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0002-4847-2985</Identifier><AffiliationInfo><Affiliation>Dompé Farmaceutici S.p.A, 67100 L'Aquila, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Pizzol</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dompé Farmaceutici S.p.A, 20122 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theurillat</LastName><ForeName>Jean-Philippe</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0003-0111-5937</Identifier><AffiliationInfo><Affiliation>Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland, 6500 Bellinzona &amp; Università della Svizzera Italiana (USI), 6900 Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allegretti</LastName><ForeName>Marcello</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0617-0233</Identifier><AffiliationInfo><Affiliation>Dompé Farmaceutici S.p.A, 67100 L'Aquila, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alimonti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland, 6500 Bellinzona &amp; Università della Svizzera Italiana (USI), 6900 Lugano, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIMM-Veneto Institute of Molecular Medicine, Foundation for Advanced Biomedical Research, 35129 Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Padova, 35122 Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Sciences and Technology, ETH Zürich, 8092 Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montopoli</LastName><ForeName>Monica</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6182-4132</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35122 Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland, 6500 Bellinzona &amp; Università della Svizzera Italiana (USI), 6900 Lugano, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIMM-Veneto Institute of Molecular Medicine, Foundation for Advanced Biomedical Research, 35129 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rugge</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Veneto Tumour Registry, Azienda Zero, 35131 Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Padova, 35122 Padova, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Dompé (Italy)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Life (Basel)</MedlineTA><NlmUniqueID>101580444</NlmUniqueID><ISSNLinking>2075-1729</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SERM</Keyword><Keyword MajorTopicYN="N">Sars-CoV-2</Keyword><Keyword MajorTopicYN="N">menopausal symptoms</Keyword><Keyword MajorTopicYN="N">osteoporosis</Keyword><Keyword MajorTopicYN="N">vitamin D</Keyword></KeywordList><CoiStatement>The authors M.C.C., M.A. and M.D.P. are employees of Dompé farmaceutici S.p.A. All authors declare no other competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39337891</ArticleId><ArticleId IdType="pmc">PMC11433321</ArticleId><ArticleId IdType="doi">10.3390/life14091107</ArticleId><ArticleId IdType="pii">life14091107</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727–733. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P., Yang X.-L., Wang X.-G., Hu B., Zhang L., Zhang W., Si H.-R., Zhu Y., Li B., Huang C.-L., et al. A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin. Nature. 2020;579:270–273. doi: 10.1038/s41586-020-2012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Falahi S., Kenarkoohi A. Sex and Gender Differences in the Outcome of Patients with COVID-19. J. Med. Virol. 2021;93:151–152. doi: 10.1002/jmv.26243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26243</ArticleId><ArticleId IdType="pmc">PMC7361270</ArticleId><ArticleId IdType="pubmed">32603509</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhindsa S., Zhang N., McPhaul M.J., Wu Z., Ghoshal A.K., Erlich E.C., Mani K., Randolph G.J., Edwards J.R., Mudd P.A., et al. Association of Circulating Sex Hormones with Inflammation and Disease Severity in Patients with COVID-19. JAMA Netw. Open. 2021;4:e2111398. doi: 10.1001/jamanetworkopen.2021.11398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11398</ArticleId><ArticleId IdType="pmc">PMC8150664</ArticleId><ArticleId IdType="pubmed">34032853</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghare Naz M.S., Banaei M., Dashti S., Tehrani F.R. An Overview of Sex Hormones in Relation to SARS-CoV-2 Infection. Future Virol. 2021;16:555–564. doi: 10.2217/fvl-2021-0058.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fvl-2021-0058</ArticleId><ArticleId IdType="pmc">PMC8293688</ArticleId><ArticleId IdType="pubmed">34306167</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipsa A., Prabhu J.S. Gender Disparity in COVID-19: Role of Sex Steroid Hormones. Asian Pac. J. Trop. Med. 2021;14:5–9. doi: 10.4103/1995-7645.304293.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1995-7645.304293</ArticleId><ArticleId IdType="pmc">PMC7610540</ArticleId><ArticleId IdType="pubmed">33828641</ArticleId></ArticleIdList></Reference><Reference><Citation>Lott N., Gebhard C.E., Bengs S., Haider A., Kuster G.M., Regitz-Zagrosek V., Gebhard C. Sex Hormones in SARS-CoV-2 Susceptibility: Key Players or Confounders? Nat. Rev. Endocrinol. 2023;19:217–231. doi: 10.1038/s41574-022-00780-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-022-00780-6</ArticleId><ArticleId IdType="pmc">PMC9734735</ArticleId><ArticleId IdType="pubmed">36494595</ArticleId></ArticleIdList></Reference><Reference><Citation>Foresta C., Rocca M.S., Di Nisio A. Gender Susceptibility to COVID-19: A Review of the Putative Role of Sex Hormones and X Chromosome. J. Endocrinol. Investig. 2021;44:951–956. doi: 10.1007/s40618-020-01383-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01383-6</ArticleId><ArticleId IdType="pmc">PMC7492232</ArticleId><ArticleId IdType="pubmed">32936429</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding A.T., Heaton N.S. The Impact of Estrogens and Their Receptors on Immunity and Inflammation during Infection. Cancers. 2022;14:909. doi: 10.3390/cancers14040909.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers14040909</ArticleId><ArticleId IdType="pmc">PMC8870346</ArticleId><ArticleId IdType="pubmed">35205657</ArticleId></ArticleIdList></Reference><Reference><Citation>Solis O., Beccari A.R., Iaconis D., Talarico C., Ruiz-Bedoya C.A., Nwachukwu J.C., Cimini A., Castelli V., Bertini R., Montopoli M., et al. The SARS-CoV-2 Spike Protein Binds and Modulates Estrogen Receptors. Sci. Adv. 2022;8:eadd4150. doi: 10.1126/sciadv.add4150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.add4150</ArticleId><ArticleId IdType="pmc">PMC9710872</ArticleId><ArticleId IdType="pubmed">36449624</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng C., Wu H., Wang M., Wang L., Zou H., Li S., Liu R. Estrogen Ameliorates Allergic Airway Inflammation by Regulating Activation of NLRP3 in Mice. Biosci. Rep. 2019;39:BSR20181117. doi: 10.1042/BSR20181117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20181117</ArticleId><ArticleId IdType="pmc">PMC6328879</ArticleId><ArticleId IdType="pubmed">30373775</ArticleId></ArticleIdList></Reference><Reference><Citation>Lahm T., Crisostomo P.R., Markel T.A., Wang M., Weil B.R., Novotny N.M., Meldrum D.R. The Effects of Estrogen on Pulmonary Artery Vasoreactivity and Hypoxic Pulmonary Vasoconstriction: Potential New Clinical Implications for an Old Hormone. Crit. Care Med. 2008;36:2174–2183. doi: 10.1097/CCM.0b013e31817d1a92.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31817d1a92</ArticleId><ArticleId IdType="pubmed">18552699</ArticleId></ArticleIdList></Reference><Reference><Citation>Fantozzi E.T., Breithaupt-Faloppa A.C., Ricardo-da-Silva F.Y., Rodrigues-Garbin S., Romero D.C., da Silva Rodrigues A., Riffo-Vasquez Y., Tavares-de-Lima W. Estradiol Mediates the Long-Lasting Lung Inflammation Induced by Intestinal Ischemia and Reperfusion. J. Surg. Res. 2018;221:1–7. doi: 10.1016/j.jss.2017.07.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2017.07.038</ArticleId><ArticleId IdType="pubmed">29229114</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan D., Ansar Ahmed S. The Immune System Is a Natural Target for Estrogen Action: Opposing Effects of Estrogen in Two Prototypical Autoimmune Diseases. Front. Immunol. 2016;6:635. doi: 10.3389/fimmu.2015.00635.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2015.00635</ArticleId><ArticleId IdType="pmc">PMC4701921</ArticleId><ArticleId IdType="pubmed">26779182</ArticleId></ArticleIdList></Reference><Reference><Citation>Montopoli M., Zorzi M., Cocetta V., Prayer-Galetti T., Guzzinati S., Bovo E., Rugge M., Calcinotto A. Clinical Outcome of SARS-CoV-2 Infection in Breast and Ovarian Cancer Patients Who Underwent Antiestrogenic Therapy. Ann. Oncol. 2021;32:676–677. doi: 10.1016/j.annonc.2021.01.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annonc.2021.01.069</ArticleId><ArticleId IdType="pmc">PMC7845554</ArticleId><ArticleId IdType="pubmed">33524477</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasso G., Mayer S.V., Winkelmann E.R., Chu T., Elliot O., Patino-Galindo J.A., Park K., Rabadan R., Honig B., Shapira S.D. A Structure-Informed Atlas of Human-Virus Interactions. Cell. 2019;178:1526–1541.e16. doi: 10.1016/j.cell.2019.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.08.005</ArticleId><ArticleId IdType="pmc">PMC6736651</ArticleId><ArticleId IdType="pubmed">31474372</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen L.M., Brannan J.M., Delos S.E., Shoemaker C.J., Stossel A., Lear C., Hoffstrom B.G., Dewald L.E., Schornberg K.L., Scully C., et al. FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection. Sci. Transl. Med. 2013;5:190ra79. doi: 10.1126/scitranslmed.3005471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3005471</ArticleId><ArticleId IdType="pmc">PMC3955358</ArticleId><ArticleId IdType="pubmed">23785035</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoemaker C.J., Schornberg K.L., Delos S.E., Scully C., Pajouhesh H., Olinger G.G., Johansen L.M., White J.M. Multiple Cationic Amphiphiles Induce a Niemann-Pick C Phenotype and Inhibit Ebola Virus Entry and Infection. PLoS ONE. 2013;8:e56265. doi: 10.1371/annotation/76780c06-ac81-48a3-8cce-509da6858fe5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/annotation/76780c06-ac81-48a3-8cce-509da6858fe5</ArticleId><ArticleId IdType="pmc">PMC3575416</ArticleId><ArticleId IdType="pubmed">23441171</ArticleId></ArticleIdList></Reference><Reference><Citation>Madrid P.B., Panchal R.G., Warren T.K., Shurtleff A.C., Endsley A.N., Green C.E., Kolokoltsov A., Davey R., Manger I.D., Gilfillan L., et al. Evaluation of Ebola Virus Inhibitors for Drug Repurposing. ACS Infect. Dis. 2015;1:317–326. doi: 10.1021/acsinfecdis.5b00030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.5b00030</ArticleId><ArticleId IdType="pubmed">27622822</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambacciani M., Levancini M. Hormone Replacement Therapy and the Prevention of Postmenopausal Osteoporosis. Prz. Menopauzalny. 2014;13:213–220. doi: 10.5114/pm.2014.44996.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/pm.2014.44996</ArticleId><ArticleId IdType="pmc">PMC4520366</ArticleId><ArticleId IdType="pubmed">26327857</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke B.L. Effects of Estrogens and SERMs on Bone Metabolism: Clinical Aspects. In: Leder B.Z., Wein M.N., editors. Osteoporosis: Pathophysiology and Clinical Management. Contemporary Endocrinology; Springer International Publishing; Cham, Switzerland: 2020. pp. 239–257.</Citation></Reference><Reference><Citation>Armeni E., Paschou S.A., Goulis D.G., Lambrinoudaki I. Hormone Therapy Regimens for Managing the Menopause and Premature Ovarian Insufficiency. Best. Pract. Res. Clin. Endocrinol. Metab. 2021;35:101561. doi: 10.1016/j.beem.2021.101561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beem.2021.101561</ArticleId><ArticleId IdType="pubmed">34274232</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandhu S.K., Hampson G. The Pathogenesis, Diagnosis, Investigation and Management of Osteoporosis. J. Clin. Pathol. 2011;64:1042–1050. doi: 10.1136/jcp.2010.077842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.2010.077842</ArticleId><ArticleId IdType="pubmed">21896577</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu K.N., Lie J.D., Wan C.K.V., Cameron M., Austel A.G., Nguyen J.K., Van K., Hyun D. Osteoporosis: A Review of Treatment Options. Pharm. Ther. 2018;43:92–104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5768298</ArticleId><ArticleId IdType="pubmed">29386866</ArticleId></ArticleIdList></Reference><Reference><Citation>Sözen T., Özışık L., Başaran N.Ç. An Overview and Management of Osteoporosis. Eur. J. Rheumatol. 2017;4:46–56. doi: 10.5152/eurjrheum.2016.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/eurjrheum.2016.048</ArticleId><ArticleId IdType="pmc">PMC5335887</ArticleId><ArticleId IdType="pubmed">28293453</ArticleId></ArticleIdList></Reference><Reference><Citation>Noh J.-Y., Yang Y., Jung H. Molecular Mechanisms and Emerging Therapeutics for Osteoporosis. Int. J. Mol. Sci. 2020;21:7623. doi: 10.3390/ijms21207623.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21207623</ArticleId><ArticleId IdType="pmc">PMC7589419</ArticleId><ArticleId IdType="pubmed">33076329</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinkerton J.V., Thomas S. Use of SERMs for Treatment in Postmenopausal Women. J. Steroid Biochem. Mol. Biol. 2014;142:142–154. doi: 10.1016/j.jsbmb.2013.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2013.12.011</ArticleId><ArticleId IdType="pubmed">24373794</ArticleId></ArticleIdList></Reference><Reference><Citation>Cauley J.A., Seeley D.G., Ensrud K., Ettinger B., Black D., Cummings S.R. Estrogen Replacement Therapy and Fractures in Older Women. Ann. Intern. Med. 1995;122:9–16. doi: 10.7326/0003-4819-122-1-199501010-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-122-1-199501010-00002</ArticleId><ArticleId IdType="pubmed">7985914</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavezzo E., Franchin E., Ciavarella C., Cuomo-Dannenburg G., Barzon L., Del Vecchio C., Rossi L., Manganelli R., Loregian A., Navarin N., et al. Suppression of a SARS-CoV-2 Outbreak in the Italian Municipality of Vo’. Nature. 2020;584:425–429. doi: 10.1038/s41586-020-2488-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2488-1</ArticleId><ArticleId IdType="pubmed">32604404</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen N.T., Chinn J., De Ferrante M., Kirby K.A., Hohmann S.F., Amin A. Male Gender Is a Predictor of Higher Mortality in Hospitalized Adults with COVID-19. PLoS ONE. 2021;16:e0254066. doi: 10.1371/journal.pone.0254066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254066</ArticleId><ArticleId IdType="pmc">PMC8270145</ArticleId><ArticleId IdType="pubmed">34242273</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino I., Barbagelata E., Ortona E., Ruggieri A., Massiah G., Giannico O.V., Politi C., Moretti A.M. Gender Differences in Patients with COVID-19: A Narrative Review. Monaldi Arch. Chest Dis. 2020;90 doi: 10.4081/monaldi.2020.1389.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/monaldi.2020.1389</ArticleId><ArticleId IdType="pubmed">32449614</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebhard C., Regitz-Zagrosek V., Neuhauser H.K., Morgan R., Klein S.L. Impact of Sex and Gender on COVID-19 Outcomes in Europe. Biol. Sex. Differ. 2020;11:29. doi: 10.1186/s13293-020-00304-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-020-00304-9</ArticleId><ArticleId IdType="pmc">PMC7247289</ArticleId><ArticleId IdType="pubmed">32450906</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J.-M., Bai P., He W., Wu F., Liu X.-F., Han D.-M., Liu S., Yang J.-K. Gender Differences in Patients with COVID-19: Focus on Severity and Mortality. Front. Public Health. 2020;8:152. doi: 10.3389/fpubh.2020.00152.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00152</ArticleId><ArticleId IdType="pmc">PMC7201103</ArticleId><ArticleId IdType="pubmed">32411652</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahimi G., Rahimi B., Panahi M., Abkhiz S., Saraygord-Afshari N., Milani M., Alizadeh E. An Overview of Betacoronaviruses-Associated Severe Respiratory Syndromes, Focusing on Sex-Type-Specific Immune Responses. Int. Immunopharmacol. 2021;92:107365. doi: 10.1016/j.intimp.2021.107365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107365</ArticleId><ArticleId IdType="pmc">PMC7797024</ArticleId><ArticleId IdType="pubmed">33440306</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholls J.M., Poon L.L.M., Lee K.C., Ng W.F., Lai S.T., Leung C.Y., Chu C.M., Hui P.K., Mak K.L., Lim W., et al. Lung Pathology of Fatal Severe Acute Respiratory Syndrome. Lancet. 2003;361:1773–1778. doi: 10.1016/S0140-6736(03)13413-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(03)13413-7</ArticleId><ArticleId IdType="pmc">PMC7112492</ArticleId><ArticleId IdType="pubmed">12781536</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlberg J., Chong D.S.Y., Lai W.Y.Y. Do Men Have a Higher Case Fatality Rate of Severe Acute Respiratory Syndrome than Women Do? Am. J. Epidemiol. 2004;159:229–231. doi: 10.1093/aje/kwh056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwh056</ArticleId><ArticleId IdType="pmc">PMC7110237</ArticleId><ArticleId IdType="pubmed">14742282</ArticleId></ArticleIdList></Reference><Reference><Citation>Channappanavar R., Fett C., Mack M., Ten Eyck P.P., Meyerholz D.K., Perlman S. Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection. J. Immunol. 2017;198:4046–4053. doi: 10.4049/jimmunol.1601896.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1601896</ArticleId><ArticleId IdType="pmc">PMC5450662</ArticleId><ArticleId IdType="pubmed">28373583</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuyama R., Nishiura H., Kutsuna S., Hayakawa K., Ohmagari N. Clinical Determinants of the Severity of Middle East Respiratory Syndrome (MERS): A Systematic Review and Meta-Analysis. BMC Public Health. 2016;16:1203. doi: 10.1186/s12889-016-3881-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-016-3881-4</ArticleId><ArticleId IdType="pmc">PMC5129628</ArticleId><ArticleId IdType="pubmed">27899100</ArticleId></ArticleIdList></Reference><Reference><Citation>Levenson A.S., Kliakhandler I.L., Svoboda K.M., Pease K.M., Kaiser S.A., Ward J.E., III, Jordan V.C. Molecular Classification of Selective Oestrogen Receptor Modulators on the Basis of Gene Expression Profiles of Breast Cancer Cells Expressing Oestrogen Receptor α. Br J. Cancer. 2002;87:449–456. doi: 10.1038/sj.bjc.6600477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjc.6600477</ArticleId><ArticleId IdType="pmc">PMC2376139</ArticleId><ArticleId IdType="pubmed">12177783</ArticleId></ArticleIdList></Reference><Reference><Citation>Levenson A.S., Wolf D.M., Catherino W.H., Takei H., Jordan V.C. Understanding the Antiestrogenic Actions of Raloxifene and a Mechanism of Drug Resistance to Tamoxifen. Breast Cancer. 1998;5:99–106. doi: 10.1007/BF02966681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02966681</ArticleId><ArticleId IdType="pubmed">11091634</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippman S.M., Brown P.H. Tamoxifen Prevention of Breast Cancer: An Instance of the Fingerpost. J. Natl. Cancer Inst. 1999;91:1809–1819. doi: 10.1093/jnci/91.21.1809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/91.21.1809</ArticleId><ArticleId IdType="pubmed">10547388</ArticleId></ArticleIdList></Reference><Reference><Citation>Rey J.R.C., Cervino E.V., Rentero M.L., Crespo E.C., Álvaro A.O., Casillas M. Raloxifene: Mechanism of Action, Effects on Bone Tissue, and Applicability in Clinical Traumatology Practice. Open Orthop. J. 2009;3:14–21. doi: 10.2174/1874325000903010014.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874325000903010014</ArticleId><ArticleId IdType="pmc">PMC2687107</ArticleId><ArticleId IdType="pubmed">19516920</ArticleId></ArticleIdList></Reference><Reference><Citation>Peretz J., Pekosz A., Lane A.P., Klein S.L. Estrogenic Compounds Reduce Influenza A Virus Replication in Primary Human Nasal Epithelial Cells Derived from Female, but Not Male, Donors. Am. J. Physiol. Lung Cell Mol. Physiol. 2016;310:L415–L425. doi: 10.1152/ajplung.00398.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00398.2015</ArticleId><ArticleId IdType="pmc">PMC4773846</ArticleId><ArticleId IdType="pubmed">26684252</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S., Chang J., Jeong K., Lee W. Raloxifene as a Treatment Option for Viral Infections. J. Microbiol. 2021;59:124–131. doi: 10.1007/s12275-021-0617-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12275-021-0617-7</ArticleId><ArticleId IdType="pmc">PMC7849956</ArticleId><ArticleId IdType="pubmed">33527314</ArticleId></ArticleIdList></Reference><Reference><Citation>Smetana K., Rosel D., BrÁbek J. Raloxifene and Bazedoxifene Could Be Promising Candidates for Preventing the COVID-19 Related Cytokine Storm, ARDS and Mortality. In Vivo. 2020;34:3027–3028. doi: 10.21873/invivo.12135.</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/invivo.12135</ArticleId><ArticleId IdType="pmc">PMC7652447</ArticleId><ArticleId IdType="pubmed">32871847</ArticleId></ArticleIdList></Reference><Reference><Citation>Allegretti M., Cesta M.C., Zippoli M., Beccari A., Talarico C., Mantelli F., Bucci E.M., Scorzolini L., Nicastri E. Repurposing the Estrogen Receptor Modulator Raloxifene to Treat SARS-CoV-2 Infection. Cell Death Differ. 2021;29:156–166. doi: 10.1038/s41418-021-00844-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-021-00844-6</ArticleId><ArticleId IdType="pmc">PMC8370058</ArticleId><ArticleId IdType="pubmed">34404919</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong K., Chang J., Park S., Kim J., Jeon S., Kim D.H., Kim Y.-E., Lee J.C., Im S., Jo Y., et al. Rapid Discovery and Classification of Inhibitors of Coronavirus Infection by Pseudovirus Screen and Amplified Luminescence Proximity Homogeneous Assay. Antivir. Res. 2023;209:105473. doi: 10.1016/j.antiviral.2022.105473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2022.105473</ArticleId><ArticleId IdType="pmc">PMC9682871</ArticleId><ArticleId IdType="pubmed">36435212</ArticleId></ArticleIdList></Reference><Reference><Citation>Dompé Farmaceutici S.P.A. Multicenter, Adaptive, Randomized, Placebo-Controlled, Double Blind, Parallel-Group Phase 2/3 Trial, to Study Efficacy and Safety of Two Doses of Raloxifene in Adult Paucisymptomatic COVID-19 Patients. clinicaltrials.gov; Bethesda, MD, USA: 2022.</Citation></Reference><Reference><Citation>Bennouar S., Cherif A.B., Kessira A., Bennouar D.-E., Abdi S. Vitamin D Deficiency and Low Serum Calcium as Predictors of Poor Prognosis in Patients with Severe COVID-19. J. Am. Coll. Nutr. 2021;40:104–110. doi: 10.1080/07315724.2020.1856013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07315724.2020.1856013</ArticleId><ArticleId IdType="pmc">PMC7814570</ArticleId><ArticleId IdType="pubmed">33434117</ArticleId></ArticleIdList></Reference><Reference><Citation>Weir E.K., Thenappan T., Bhargava M., Chen Y. Does Vitamin D Deficiency Increase the Severity of COVID-19? Clin. Med. 2020;20:e107–e108. doi: 10.7861/clinmed.2020-0301.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0301</ArticleId><ArticleId IdType="pmc">PMC7385774</ArticleId><ArticleId IdType="pubmed">32503801</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M.-K., Yu X.-L., Zhou L.-Y., Si H.-M., Hui J.-F., Yang J.-S. Potential Role of Vitamin D in Patients with Diabetes, Dyslipidaemia, and COVID-19. World J. Crit. Care Med. 2022;11:112–114. doi: 10.5492/wjccm.v11.i2.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.5492/wjccm.v11.i2.112</ArticleId><ArticleId IdType="pmc">PMC8968481</ArticleId><ArticleId IdType="pubmed">35433313</ArticleId></ArticleIdList></Reference><Reference><Citation>Thacher T.D. Evaluating the Evidence in Clinical Studies of Vitamin D in COVID-19. Nutrients. 2022;14:464. doi: 10.3390/nu14030464.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14030464</ArticleId><ArticleId IdType="pmc">PMC8837985</ArticleId><ArticleId IdType="pubmed">35276822</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsche L., Glauner B., von Mendel J. COVID-19 Mortality Risk Correlates Inversely with Vitamin D3 Status, and a Mortality Rate Close to Zero Could Theoretically Be Achieved at 50 Ng/ML 25(OH)D3: Results of a Systematic Review and Meta-Analysis. Nutrients. 2021;13:3596. doi: 10.3390/nu13103596.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13103596</ArticleId><ArticleId IdType="pmc">PMC8541492</ArticleId><ArticleId IdType="pubmed">34684596</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutolo M., Paolino S., Sulli A., Smith V., Pizzorni C., Seriolo B. Vitamin D, Steroid Hormones, and Autoimmunity. Ann. N. Y Acad. Sci. 2014;1317:39–46. doi: 10.1111/nyas.12432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.12432</ArticleId><ArticleId IdType="pubmed">24739090</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolliffe D.A., Camargo C.A., Sluyter J.D., Aglipay M., Aloia J.F., Ganmaa D., Bergman P., Bischoff-Ferrari H.A., Borzutzky A., Damsgaard C.T., et al. Vitamin D Supplementation to Prevent Acute Respiratory Infections: A Systematic Review and Meta-Analysis of Aggregate Data from Randomised Controlled Trials. Lancet Diabetes Endocrinol. 2021;9:276–292. doi: 10.1016/S2213-8587(21)00051-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(21)00051-6</ArticleId><ArticleId IdType="pubmed">33798465</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau A.R., Jolliffe D.A., Hooper R.L., Greenberg L., Aloia J.F., Bergman P., Dubnov-Raz G., Esposito S., Ganmaa D., Ginde A.A., et al. Vitamin D Supplementation to Prevent Acute Respiratory Tract Infections: Systematic Review and Meta-Analysis of Individual Participant Data. BMJ. 2017;356:i6583. doi: 10.1136/bmj.i6583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i6583</ArticleId><ArticleId IdType="pmc">PMC5310969</ArticleId><ArticleId IdType="pubmed">28202713</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Mei K., Xie L., Yuan P., Ma J., Yu P., Zhu W., Zheng C., Liu X. Low Vitamin D Levels Do Not Aggravate COVID-19 Risk or Death, and Vitamin D Supplementation Does Not Improve Outcomes in Hospitalized Patients with COVID-19: A Meta-Analysis and GRADE Assessment of Cohort Studies and RCTs. Nutr. J. 2021;20:89. doi: 10.1186/s12937-021-00744-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12937-021-00744-y</ArticleId><ArticleId IdType="pmc">PMC8557713</ArticleId><ArticleId IdType="pubmed">34719404</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L., Frara S., Nannipieri F., Cotellessa A., Locatelli M., Rovere Querini P., Giustina A. Low Vitamin D Levels Are Associated with Long COVID Syndrome in COVID-19 Survivors. J. Clin. Endocrinol. Metab. 2023;108:e1106–e1116. doi: 10.1210/clinem/dgad207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgad207</ArticleId><ArticleId IdType="pmc">PMC10505553</ArticleId><ArticleId IdType="pubmed">37051747</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah K., Varna V.P., Sharma U., Mavalankar D. Does Vitamin D Supplementation Reduce COVID-19 Severity?—A Systematic Review. QJM. 2022;115:hcac040. doi: 10.1093/qjmed/hcac040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcac040</ArticleId><ArticleId IdType="pmc">PMC9383458</ArticleId><ArticleId IdType="pubmed">35166850</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Kuang X., Li K., Guo X., Deng Q., Li D. Effects of Combined Calcium and Vitamin D Supplementation on Osteoporosis in Postmenopausal Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Food Funct. 2020;11:10817–10827. doi: 10.1039/D0FO00787K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D0FO00787K</ArticleId><ArticleId IdType="pubmed">33237064</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J.-K., Zhang W.-H., Zou L., Liu Y., Li J.-J., Kan X.-H., Dai L., Shi Q.-K., Yuan S.-T., Yu W.-K., et al. Serum Calcium as a Biomarker of Clinical Severity and Prognosis in Patients with Coronavirus Disease 2019. Aging. 2020;12:11287–11295. doi: 10.18632/aging.103526.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103526</ArticleId><ArticleId IdType="pmc">PMC7343468</ArticleId><ArticleId IdType="pubmed">32589164</ArticleId></ArticleIdList></Reference><Reference><Citation>Elham A.S., Azam K., Azam J., Mostafa L., Nasrin B., Marzieh N. Serum Vitamin D, Calcium, and Zinc Levels in Patients with COVID-19. Clin. Nutr. ESPEN. 2021;43:276–282. doi: 10.1016/j.clnesp.2021.03.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2021.03.040</ArticleId><ArticleId IdType="pmc">PMC8053215</ArticleId><ArticleId IdType="pubmed">34024527</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlansky S., Sallinger M., Grabmayr H., Humer C., Bernhard A., Fahrner M., Frischauf I. Calcium Signals during SARS-CoV-2 Infection: Assessing the Potential of Emerging Therapies. Cells. 2022;11:253. doi: 10.3390/cells11020253.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11020253</ArticleId><ArticleId IdType="pmc">PMC8773957</ArticleId><ArticleId IdType="pubmed">35053369</ArticleId></ArticleIdList></Reference><Reference><Citation>Osman W., Al Fahdi F., Al Salmi I., Al Khalili H., Gokhale A., Khamis F. Serum Calcium and Vitamin D Levels: Correlation with Severity of COVID-19 in Hospitalized Patients in Royal Hospital, Oman. Int. J. Infect. Dis. 2021;107:153–163. doi: 10.1016/j.ijid.2021.04.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.04.050</ArticleId><ArticleId IdType="pmc">PMC8057687</ArticleId><ArticleId IdType="pubmed">33892191</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoenaker D.A.J.M., Jackson C.A., Rowlands J.V., Mishra G.D. Socioeconomic Position, Lifestyle Factors and Age at Natural Menopause: A Systematic Review and Meta-Analyses of Studies across Six Continents. Int. J. Epidemiol. 2014;43:1542–1562. doi: 10.1093/ije/dyu094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyu094</ArticleId><ArticleId IdType="pmc">PMC4190515</ArticleId><ArticleId IdType="pubmed">24771324</ArticleId></ArticleIdList></Reference><Reference><Citation> [(accessed on 1 February 2021)].  Available online:  www.eshre.eu/Guidelines-and-Legal/Guidelines/Management-of-premature-ovarian-insufficiency.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>